These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26982070)

  • 1. [Transdermal estrogen spray in therapy of postmenopausal syndrome].
    Fait T
    Ceska Gynekol; 2016 Jan; 81(1):77-80. PubMed ID: 26982070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of estradiol metered-dose transdermal spray in clinical practice.
    Fait T; Fialova A; Pastor Z
    Climacteric; 2018 Dec; 21(6):549-553. PubMed ID: 30296172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Climacteric syndrome].
    Imthurn B; Maurer-Major E
    Ther Umsch; 2000 Oct; 57(10):595-9. PubMed ID: 11081369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.
    Kovács G; Zelei T; Vokó Z
    Climacteric; 2016 Oct; 19(5):488-95. PubMed ID: 27593417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D; Rovati LC; Giacovelli G; Setnikar I; Bottiglioni F
    Arzneimittelforschung; 2000 Mar; 50(3):293-300. PubMed ID: 10758784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Alora Study Group.
    Good WR; John VA; Ramirez M; Higgins JE
    Climacteric; 1999 Mar; 2(1):29-36. PubMed ID: 11915854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a new transdermal delivery system for estrogen replacement therapy in postmenopausal women.
    Figueroa-Casas PR; Alfonsin A; Arrighi A; Bluvstein G; Del Castillo R; Goldsman T; Inglesi J; Itala J; Novelli J; Monti C
    Maturitas; 1994 Dec; 20(2-3):139-44. PubMed ID: 7715465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE; Koltun WD; Pascual ML; Day WW; Peterson C
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerodiol versus the transdermal route: perspectives for patient preference.
    Lopes P; Rozenberg S; Graaf J; Fernandez-Villoria E; Marianowski L
    Maturitas; 2001 Jun; 38 Suppl 1():S31-9. PubMed ID: 11390122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of transdermal hormone replacement therapy on vasomotor symptoms in perimenopausal women].
    Rozmus-Warcholińska W; Skrzypulec V; Drosdzol A; Kowalczyk R; Nowosielski K; Piela B; Walaszek A
    Wiad Lek; 2004; 57 Suppl 1():254-8. PubMed ID: 15884251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
    Sajtos B; Herold J; Winkler UH; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal estrogen therapy.
    Connell EB
    Postgrad Med; 1997 Jun; 101(6):115-6, 122, 128-30 passim. PubMed ID: 9194869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF; Pickar JH; MacAllister DC; Warren MP
    Menopause; 2012 Jun; 19(6):622-9. PubMed ID: 22282101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy.
    Tuomikoski P; Mikkola TS; Tikkanen MJ; Ylikorkala O
    Climacteric; 2010 Oct; 13(5):457-66. PubMed ID: 20443719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
    Palacios S
    Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.